Literature DB >> 32299104

Mitochondrial carrier homolog 2 is necessary for AML survival.

Dilshad H Khan1, Michael Mullokandov2, Yan Wu1, Veronique Voisin3, Marcela Gronda1, Rose Hurren1, Xiaoming Wang1, Neil MacLean1, Danny V Jeyaraju1, Yulia Jitkova1, G Wei Xu1, Rob Laister1, Ayesh Seneviratne1, Zachary M Blatman1, Troy Ketela1, Gary D Bader3,4, Sajid A Marhon1, Daniel D De Carvalho1, Mark D Minden1, Atan Gross2, Aaron D Schimmer1.   

Abstract

Through a clustered regularly insterspaced short palindromic repeats (CRISPR) screen to identify mitochondrial genes necessary for the growth of acute myeloid leukemia (AML) cells, we identified the mitochondrial outer membrane protein mitochondrial carrier homolog 2 (MTCH2). In AML, knockdown of MTCH2 decreased growth, reduced engraftment potential of stem cells, and induced differentiation. Inhibiting MTCH2 in AML cells increased nuclear pyruvate and pyruvate dehydrogenase (PDH), which induced histone acetylation and subsequently promoted the differentiation of AML cells. Thus, we have defined a new mechanism by which mitochondria and metabolism regulate AML stem cells and gene expression.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32299104     DOI: 10.1182/blood.2019000106

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  CRISPR Turbo Accelerated KnockOut (CRISPy TAKO) for Rapid in vivo Screening of Gene Function.

Authors:  Sonja L Plasil; Amit Seth; Gregg E Homanics
Journal:  Front Genome Ed       Date:  2020-10-21

2.  Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer's disease.

Authors:  Jake Gockley; Kelsey S Montgomery; William L Poehlman; Jesse C Wiley; Yue Liu; Ekaterina Gerasimov; Anna K Greenwood; Solveig K Sieberts; Aliza P Wingo; Thomas S Wingo; Lara M Mangravite; Benjamin A Logsdon
Journal:  Genome Med       Date:  2021-05-04       Impact factor: 11.117

Review 3.  Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy.

Authors:  Tingting Hu; Zhou Qin; Chao Shen; Han-Lin Gong; Zhi-Yao He
Journal:  Front Bioeng Biotechnol       Date:  2021-11-24

Review 4.  Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications.

Authors:  Maheswaran Solayappan; Adam Azlan; Kang Zi Khor; Mot Yee Yik; Matiullah Khan; Narazah Mohd Yusoff; Emmanuel Jairaj Moses
Journal:  Front Genet       Date:  2022-01-28       Impact factor: 4.599

5.  The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.

Authors:  Geethu Emily Thomas; Grace Egan; Laura García-Prat; Aaron Botham; Veronique Voisin; Parasvi S Patel; Fieke W Hoff; Jordan Chin; Boaz Nachmias; Kerstin B Kaufmann; Dilshad H Khan; Rose Hurren; Xiaoming Wang; Marcela Gronda; Neil MacLean; Cristiana O'Brien; Rashim P Singh; Courtney L Jones; Shane M Harding; Brian Raught; Andrea Arruda; Mark D Minden; Gary D Bader; Razq Hakem; Steve Kornblau; John E Dick; Aaron D Schimmer
Journal:  Nat Cell Biol       Date:  2022-06-06       Impact factor: 28.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.